Insiders · ARCT

ARCT insider transactions

Arcturus Therapeutics Holdings Inc. (ARCT) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for ARCT

• 34d
  SEC Form 4 filed by Chief Financial Officer Mulroy Dennis

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 34d
  SEC Form 3 filed by new insider Mulroy Dennis

  3 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 173d
  SEC Form 4 filed by Controller Roberts Joseph

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 173d
  SEC Form 4 filed by Chief Scientific Officer & COO Chivukula Pad

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 173d
  SEC Form 4 filed by President and CEO Payne Joseph E

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 173d
  SEC Form 4 filed by Chief Legal Officer Kurata Lance

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 173d
  New insider Roberts Joseph claimed ownership of 2,201 shares (SEC Form 3)

  3 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 294d
  Amendment: Chief Financial Officer Sassine Andy bought $20,499 worth of shares (1,238 units at $16.56), increasing direct ownership by 0.56% to 221,764 units (SEC Form 4)

  4/A - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 295d
  Chief Financial Officer Sassine Andy decreased direct ownership by 0.56% to 221,764 units (SEC Form 4)

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 364d
  SEC Form 4 filed by Director Farrell Peter C

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 364d
  SEC Form 4 filed by Director Slaoui Moncef

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 364d
  SEC Form 4 filed by Director Marquet Magda

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 364d
  SEC Form 4 filed by Director Markels John

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 364d
  SEC Form 4 filed by Director Marantz Jing L.

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 364d
  SEC Form 4 filed by Director Barlow James F

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 364d
  SEC Form 4 filed by Director Holmes Edward W

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 539d
  SEC Form 4 filed by Chief Legal Officer Kurata Lance

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 539d
  SEC Form 4 filed by President and CEO Payne Joseph E

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 539d
  SEC Form 4 filed by Chief Scientific Officer & COO Chivukula Pad

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 539d
  SEC Form 4 filed by Chief Financial Officer Sassine Andy

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 602d
  Chief Scientific Officer & COO Chivukula Pad sold $249,121 worth of shares (12,000 units at $20.76), decreasing direct ownership by 3% to 435,334 units (SEC Form 4)

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 719d
  SEC Form 4 filed by Director Slaoui Moncef

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 719d
  SEC Form 3 filed by new insider Slaoui Moncef

  3 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 722d
  Director Marantz Jing L. converted options into 3,131 shares (SEC Form 4)

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 722d
  Director Holmes Edward W converted options into 3,131 shares (SEC Form 4)

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 722d
  Director Markels John converted options into 3,131 shares (SEC Form 4)

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 722d
  Director Marquet Magda converted options into 3,131 shares (SEC Form 4)

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 722d
  Director Barlow James F converted options into 3,131 shares, increasing direct ownership by 31% to 13,131 units (SEC Form 4)

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 722d
  Director Farrell Peter C converted options into 3,131 shares, increasing direct ownership by 6% to 55,741 units (SEC Form 4)

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 726d
  Chief Financial Officer Sassine Andy sold $1,601,500 worth of shares (50,000 units at $32.03), decreasing direct ownership by 18% to 220,526 units (SEC Form 4)

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 733d
  Chivukula Pad sold $5,130 worth of shares (114 units at $45.00), decreasing direct ownership by 0.03% to 447,334 units (SEC Form 4)

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 736d
  Chivukula Pad sold $1,040,234 worth of shares (26,000 units at $40.01), decreasing direct ownership by 5% to 447,448 units (SEC Form 4)

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 805d
  Chivukula Pad sold $610,574 worth of shares (17,435 units at $35.02), decreasing direct ownership by 4% to 473,448 units (SEC Form 4)

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 811d
  Chivukula Pad sold $299,839 worth of shares (8,565 units at $35.01), decreasing direct ownership by 2% to 490,883 units (SEC Form 4)

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 904d
  SEC Form 4 filed by Sassine Andy

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 904d
  SEC Form 4 filed by Chivukula Pad

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 904d
  SEC Form 4 filed by Kurata Lance

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 904d
  SEC Form 4 filed by Kummerfeld Keith C

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 904d
  SEC Form 4 filed by Payne Joseph E

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 950d
  Chivukula Pad sold $93,602 worth of shares (5,000 units at $18.72), decreasing direct ownership by 0.99% to 499,448 units (SEC Form 4)

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 980d
  Chivukula Pad sold $128,062 worth of shares (5,000 units at $25.61), decreasing direct ownership by 0.98% to 504,448 units (SEC Form 4)

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 1009d
  SEC Form 4: Chivukula Pad sold $157,264 worth of shares (5,000 units at $31.45), decreasing direct ownership by 0.97% to 509,448 units

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 1028d
  SEC Form 4: Sassine Andy was granted 1,223 shares, increasing direct ownership by 0.45% to 270,526 units

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 1042d
  SEC Form 4: Chivukula Pad sold $174,550 worth of shares (5,000 units at $34.91), decreasing direct ownership by 0.96% to 514,448 units

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 1042d
  SEC Form 4 filed by Markels John

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 1042d
  SEC Form 4 filed by Marantz Jing L.

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 1042d
  SEC Form 4 filed by Farrell Peter C

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 1042d
  SEC Form 4 filed by Holmes Edward W

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 1042d
  SEC Form 4 filed by Barlow James F

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 1042d
  SEC Form 4 filed by Marquet Magda

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 1058d
  SEC Form 4 filed by Chivukula Pad

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 1058d
  SEC Form 4 filed by Kummerfeld Keith C

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 1070d
  SEC Form 4 filed by Chivukula Pad

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 1101d
  SEC Form 4 filed by Chivukula Pad

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 1125d
  SEC Form 4 filed by Chivukula Pad

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 1134d
  SEC Form 4 filed by Chivukula Pad

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 1148d
  SEC Form 4 filed by Kummerfeld Keith C

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 1162d
  SEC Form 4 filed by Chivukula Pad

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 1190d
  SEC Form 4: Chivukula Pad sold $80,350 worth of shares (5,000 units at $16.07) as part of a pre-agreed trading plan, decreasing direct ownership by 0.84% to 589,448 units

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)
• 1269d
  SEC Form 4: Marquet Magda bought $39,996 worth of shares (2,222 units at $18.00)

  4 - Arcturus Therapeutics Holdings Inc. (0001768224) (Issuer)